Industry News External News
Biotechnology Articles
Industry News External News
Singapore biotech startup Lucence expands across Asia, US as demand grows for preventive health tests - The Business Times
Google News – Biotech Funding External News
Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New York - Global Legal Chronicle
Google News – Cardiology External News
Fallout from Quantum Genomics' phase 3 fail claims top executives as biotech searches for a future - Fierce Biotech
Google News – Oncology External News
GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’ - Fierce Biotech
Google News – Oncology External News
Biotechnology Value Fund group (NASDAQ: PYXS) reports 9.99% capped stake in Pyxis - Stock Titan
Google News – Oncology External News
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer - Fierce Biotech
Google News – NIH External News
Apertura and NIH institutes to test gene therapy for NPC1 - Pharmaceutical Technology
Google News – EMA (biotech/pharma) External News
LEO Pharma submits adolescent label expansion application for Anzupgo® to EMA - Via Ritzau
Google News – FDA (biotech/pharma) External News
OKYO Pharma clears key FDA milestone, advances toward Phase 3 trial for Neuropathic corneal pain - Proactive financial news
Google News – FDA (biotech/pharma) External News
Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit - Fierce Biotech
Google News – FDA (biotech/pharma) External News
FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time - Fierce Pharma
Google News – FDA (biotech/pharma) External News
FDA returns to releasing pharma rejection letters with 14 new CRLs - Endpoints News
Google News – FDA (biotech/pharma) External News
FDA discloses why drugs don’t make it to market. A pharma company says it’s bad for business - MassLive
Google News – FDA (biotech/pharma) External News